The opportunities of third-generation cephalosporin usage in outpatient surgery


  • V.V. Nikonov Kharkiv Medical Academy of Postgraduate Education of the Ministry of Health of Ukraine, Kharkiv, Ukraine
  • K.I. Lysohub Kharkiv Medical Academy of Postgraduate Education of the Ministry of Health of Ukraine, Kharkiv, Ukraine
  • M.V. Lysohub SI “Sytenko Institute of Spine and Joint Pathology National Academy of Medical Sciences of Ukraine”, Kharkiv, Ukraine



third-generation cephalosporin, cefdinir, non-complicated infections of skin and soft tissue, switch therapy


The adherence to the principles of rational antibacterial therapy is of great significance, namely the prescription of a medication to achieve the quickest possible clinical and bacteriologic convalescence, the spectrum of mechanisms of a drug should affect possible germ, overcome the possible mechanisms of resistance and make the highest concentration in infectious focus. Moreover, the prescribed drug should be convenient for outpatient usage. The important principle of infection treatment is a de-escalation therapy that provides clinical and economic benefits both for a patient and health facility. The usage of the antibiotic cefdinir is effective and safe in hospital and outpatient treatment.


Download data is not yet available.


Kozlov R.S., Krechikova O.I., Ivanchik N.V. et al. Etiology of Nosocomial Bacterial Infections in Russia. Rosnet Study Group. Proceedings of the 48th Interscience Conference on Antimicrobial Agents and Chemotherapy. 2008 Oct 25-28. Washington, DC, USA. Р. 572. Abstr. K-4108.

Pulgar S., Mehra M., Quintana A. et al. The epidemiology of hospitalized cases of skin and soft tissue infection in Europe. 18th European Congress of Clinical Microbiology and Infectious Diseases. Barcelona, Spain, 2008. Abstr. P82.

DiNubile M.J., Lipsky B.A. Complicated infections of skin and skin structure infections: When infection is more than skin deep. J. Antimicrob. Chemother. 2004. 53. 37-50.

Bowler P.G., Duerden B.I., Armstrong D.G. Wound microbiology and associated approaches to wound management. Clin. Microbiol. Rev. 2001. 14(2). 244-269.

Stevens D.L., Bisno A.L., Chambers H.F. et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. ULR:

Kittang B.R., Langeland N., Skrede S., Mylvaganam H. Two unusual cases of severe soft tissue infection caused by Streptococcus dysgalactiae subsp. equisimilis. J. Clin. Microbiol. 2010 Apr. 48(4). 1484-7.

Абатуров А.Е., Крючко Т.А. Настоящая и будущая этиологическая терапия пневмоний. Здоров’я дитини. 2017. Т. 12. № 3.

Заплатников А.Л., Гирина А.А., Леписева И.В. Алгоритмы стартовой этиотропной терапии при бактериальных инфекциях верхних дыхательных путей у детей. Медицинский совет. 2016. 1. 44-49.

Carmeli Y., Lidji S.K., Shabtai E., Navon-Venezia S., Schwaber M.J. The effects of group 1 versus group 2 carbapenems on imipenem-resistant Pseudomonas aeruginosa: an ecological study. Diagn. Microbiol. Infect. Dis. 2011. 70(3). 367-372.

Howard B.M., Pinney R.J., Smith J.T. Post-antibiotic effects of cefdinir on Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus pyrogenes. Chemotherapy. Jul-Aug 1994. 40(4). 232-8.

Carmelli Y. Strategies for managing today’s infections. Clin. Microbiol. Infect. 2008. 14 Suppl 3. 22-31. 42.

Calderwod S. Cephalosporins. Basow D.S. (Ed). UpToDate [database on the internet]. Waltham (MA): UpToDate; 2010 [cited 2012 Jul 31]. Antiinfectives 8:00, Antibacterials 8:12, Cephalosporins 8:12.06. McEvoy G.K., ed. American Hospital Formulary Services, AHFS Drug Information 2011 [monograph on the internet]. Bethesda (MD): American Society of Health-System Pharmacists; 2012 [cited 2012 Jul 31].

Guay D.R.P. Cefdinir: an advanced-generation, broad-spectrum oral cephalosporin. Clin. Ther. 2002 Apr. 24(4). 473-89. doi: 10.1016/s0149-2918(02)85125-6.

Brook І., Foote P.A. Efficacy of Penicillin versus Cefdinir in Eradication of Group A Streptococci and Tonsillar Flora. Antimicrob. Agents Chemother. 2005 Nov. 49(11). 4787-4788.

Голуб А.В., Привольнев В.В. Системная антибактериальная терапия хирургических инфекций кожи и мягких тканей в амбулаторных условиях: что должен знать каждый хирург? Амбулаторная хирургия. Стационарозамещающие технологии. 2014. 3–4(55–56).

Boschert S. Shorter Course of Once-Daily Cefdinir Treats Skin Infections. Infectious Diseases. September 2007. 27.

Stevanovic T., Komazec Z., Lemajic-Komazec S., Jovic R. Acute otitis media: to follow-up or treat? Int. J. Pediatr. Otorhinolaryngol. 2010 Aug. 74(8). 930-3. doi: 10.1016/j.ijporl.2010.05.017. Epub 2010 Jun 17.

Савинова Т.А., Сидоренко С.В., Буданов С.В., Грудинина С.А. Динамика распространения резистентности к бета-лактамным антибиотикам среди Streptococcus pneumoniae и ее клиническая значимость. Антибиотики и химиотерапия. 2010. 55. 12-20.

Sader H.S., Jones R.N. Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections. Expert Rev. Anti Infect. Ther. 2007 Feb. 5(1). 29-43. doi: 10.1586/14787210.5.1.29.

Kester М., Kelly D., Kent К., Vrana Н. Treatment of Infectious Diseases. Elsevier’s Integrated Review Pharmacology. Second Edition. 2012. P. 41-78.

Mertz D. et al. Outcomes of early switching from intravenous to oral antibiotics on medical wards. J. Antimicrob. Chemother. 2009. 64. Р. 188-99.

IV to Oral Switch Clinical Guideline for adult patients: Can antibiotics S.T.O.P. Approval date: 23 October 2017.

Жерносек В.Ф. Новые возможности антибактериальной терапии острых инфекций дыхательных и мочевых путей у детей в амбулаторных условиях. Медицинские новости. 2016. № 8.

Bowlware K.L., Stull Т. Антибактериальные препараты в педиатрии. Новости медицины и фармации. 2007. 20(228).



How to Cite

Nikonov, V., Lysohub, K., & Lysohub, M. (2021). The opportunities of third-generation cephalosporin usage in outpatient surgery. EMERGENCY MEDICINE, 17(3), 30–35.




Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 > >>